Insulin Aspart Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Insulin Aspart Injection (injection) from Novo Nordisk, Inc. with status No longer listed by FDA. The shortage was first posted on Jul 21, 2025.
Shortage details
- Status
- No longer listed by FDA
- Company
- Novo Nordisk, Inc.
- Package NDC
- 73070-102-15
- Dosage Form
- Injection
- Presentation
- Insulin Aspart, Injection, 3 mL Insulin Aspart PenFill® cartridge (NDC 73070-102-15)
- Initial Posting
- Jul 21, 2025